General Announcement::Filing and approval of the Red Herring Prospectus dated July 19 2021 of our Wholly Owned Subsidiary

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-Jul-2021 16:09:17
Status
New
Announcement Sub Title
Filing and approval of the Red Herring Prospectus dated July 19 2021 of our Wholly Owned Subsidiary
Announcement Reference
SG210720OTHR1S6T
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below)
Filing and approval of the Red Herring Prospectus dated July 19, 2021 of our wholly owned subsidiary Glenmark Life Sciences Limited in connection with its proposed initial public offering of equity shares Offer or IPO.

Attachments

SGX_RHP_20072021.pdf
Total size =654K